Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC39A3 - Matrigel 3D culture model of JIMT1 breast cancer cells
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC39A3 - Duchenne muscular dystrophy (II) (HG-U95B)
SLC39A3 - Obese children: omental adipose tissue
SLC39A3 - Metastatic prostate cancer (HG-U95B)
GEO DataSets Gene Chromosome neighbors Homologene neighbors
SLC39A3 - Myelodysplastic syndrome disorder: bone marrow mesenchymal stromal cells
SLC39A3 - Oral histone deacetylase inhibitor ST7612AA1 effect on diffuse large B-cell lymphoma in vitro models
SLC39A3 - Hypoxia and 2-oxoglutrate-dependent dioxygenase inhibition (Human-6 BeadChip)
SLC39A3 - Hypoxia effect on vhl and p53 null mutants
SLC39A3 - Teratozoospermia (HumanRef-8 BeadChip)
SLC39A3 - Myelodysplastic syndromes: CD34+ cells
SLC39A3 - DEK oncogene deficiency effect in U937 leukemic monocyte lymphoma cells
SLC39A3 - Cytogenetically normal acute myeloid leukemia_training set (HG-U133B)
SLC39A3 - Pirin depletion effect on myelomonocytic cell line
SLC39A3 - StemRegenin 1 effect on hematopoietic stem cells: dose response
SLC39A3 - Cystic fibrosis pathology and 4-phenylbutyrate (HG-U133B)
SLC39A3 - Skeletal repair in non-union fractures (HG-U95B)
SLC39A3 - Imatinib mesylate effect on EOL-1 eosinophilic leukemia cell line
SLC39A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A3 - Myelodysplastic syndrome: CD34+ hematopoietic stem cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on